Get the Stockscreener App
23.91
0.29%
0.07
After Hours:
23.91
Acadia Healthcare Company Inc stock is traded at $23.91, with a volume of 6.31M.
It is up +0.29% in the last 24 hours and down -18.76% over the past month.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the major proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.
See More
Previous Close:
$23.84
Open:
$23.75
24h Volume:
6.31M
Relative Volume:
3.17
Market Cap:
$2.43B
Revenue:
$3.12B
Net Income/Loss:
$280.73M
P/E Ratio:
7.8393
EPS:
3.05
Net Cash Flow:
$-496.32M
1W Performance:
-11.71%
1M Performance:
-18.76%
6M Performance:
-59.69%
1Y Performance:
-65.96%
1-Day Range:
$23.36
$24.34
1-Week Range:
$23.36
$27.45
52-Week Range:
$23.36
$82.41
Acadia Healthcare Company Inc Stock (ACHC) Company Profile
Name
Acadia Healthcare Company Inc
Sector
Industry
Phone
615-861-6000
Address
6100 TOWER CIRCLE, FRANKLIN, TN
Compare ACHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACHC
Acadia Healthcare Company Inc
|
23.91 | 2.43B | 3.12B | 280.73M | -496.32M | 3.05 |
|
HCA
Hca Healthcare Inc
|
335.01 | 83.86B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.65 | 14.48B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
DVA
Davita Inc
|
140.03 | 12.07B | 12.67B | 827.68M | 1.42B | 9.27 |
|
THC
Tenet Healthcare Corp
|
121.81 | 11.79B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
174.80 | 11.66B | 15.42B | 1.03B | 956.84M | 15.02 |
Acadia Healthcare Company Inc Stock (ACHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-28-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-07-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-12-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-25-24 | Upgrade | Deutsche Bank | Sell → Hold |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Apr-20-23 | Downgrade | Deutsche Bank | Hold → Sell |
| Dec-12-22 | Upgrade | Loop Capital | Hold → Buy |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-24-21 | Initiated | UBS | Buy |
| Sep-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Aug-12-21 | Initiated | Barclays | Underweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| Nov-17-20 | Upgrade | UBS | Neutral → Buy |
| Sep-30-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-28-20 | Initiated | Stephens | Equal-Weight |
| Dec-11-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jul-31-19 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jan-03-19 | Initiated | Deutsche Bank | Hold |
| Nov-16-18 | Initiated | UBS | Neutral |
| Jan-30-18 | Resumed | Wells Fargo | Outperform |
| Nov-03-17 | Initiated | Credit Suisse | Neutral |
| Oct-25-17 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-25-17 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-28-17 | Reiterated | Mizuho | Buy |
| Jul-18-17 | Initiated | William Blair | Outperform |
| May-15-17 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
| Feb-27-17 | Reiterated | Mizuho | Buy |
| Jan-27-17 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-11-17 | Reiterated | KeyBanc Capital Mkts | Overweight |
| Jan-04-17 | Initiated | Citigroup | Buy |
| Dec-02-16 | Resumed | Jefferies | Buy |
View All
Acadia Healthcare Company Inc Stock (ACHC) Latest News
Should You Investigate Acadia Healthcare Company, Inc. (NASDAQ:ACHC) At US$23.91? - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Encourages Acadia Healthcare Company, Inc. (ACHC) Shareholders to Inquire about Securities Investigation - markets.businessinsider.com
Hospital Chains Stocks Q4 Teardown: Acadia Healthcare (NASDAQ:ACHC) Vs The Rest - Yahoo Finance
Acadia Healthcare Announces Date for First Quarter 2025 Earnings Release - Business Wire
3 Reasons to Avoid ACHC and 1 Stock to Buy Instead - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Acadia Healthcare Company, Inc. (ACHC) And Encourages Shareholders to Connect - markets.businessinsider.com
Acadia Healthcare stock hits 52-week low at $25.38 - Investing.com
LPL Financial LLC Acquires 2,869 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) - Defense World
Alliancebernstein L.P. Sells 149,131 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) - Defense World
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Sold by Franklin Resources Inc. - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Acadia Healthcare Company, Inc. (ACHC) And Encourages Shareholders to Reach Out - markets.businessinsider.com
American Century Companies Inc. Cuts Stock Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) - Defense World
Is Acadia Healthcare (ACHC) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? - Yahoo Finance
Acadia Healthcare (NASDAQ:ACHC) Earns Buy Rating from Analysts at Guggenheim - The AM Reporter
Guggenheim Begins Coverage on Acadia Healthcare (NASDAQ:ACHC) - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Acadia Healthcare Company, Inc. (ACHC) and Encourages Shareholders to Learn More About the Investigation - markets.businessinsider.com
Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? - Yahoo Finance
Is Acadia Healthcare Co Gaining or Losing Market Support? - Benzinga
Guggenheim Initiates Acadia Healthcare With Buy Rating, $36 Price Target - MarketScreener
Brokerages Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) PT at $52.19 - The AM Reporter
Bronstein, Gewirtz & Grossman, LLC Encourages Acadia Healthcare Company, Inc. (ACHC) Stockholders to Inquire about Securities Investigation - markets.businessinsider.com
JPMorgan Chase & Co. Has $32.36 Million Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) - Defense World
Behavioral Therapy Market Set to Witness Significant Growth - openPR.com
Growth Drivers of Behavioural Health Treatment Market - openPR.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Acadia Healthcare Company, Inc. (ACHC) and Encourages Investors to Learn More About the Investigation - markets.businessinsider.com
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Acadia Healthcare stock hits 52-week low at $27.6 - Investing.com Australia
Cantor Fitzgerald maintains Acadia Healthcare Neutral rating By Investing.com - Investing.com Canada
Acadia Healthcare stock hits 52-week low at $27.6 By Investing.com - Investing.com Canada
New Strong Sell Stocks for April 4th - TradingView
Short Interest in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Expands By 27.3% - MarketBeat
4th+Circuit%3A+Healthcare+False+Claims+Act+lawsuit+is+reinstated%C2%A0 - North Carolina Lawyers Weekly
Acadia Healthcare Company, Inc. (ACHC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
4th+Circuit%3A+Healthcare+False+Claims+Act+lawsuit+is+reinstated%C2%A0%C2%A0 - South Carolina Lawyers Weekly
Cantor Fitzgerald maintains Neutral on Acadia Healthcare stock By Investing.com - Investing.com Canada
Bronstein, Gewirtz & Grossman, LLC Is Investigating Acadia Healthcare Company, Inc. (ACHC) And Encourages Investors to Connect - markets.businessinsider.com
5 Stock Picks Last Month From Wall Street's Most Accurate Analysts - Benzinga
Short Interest in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Increases By 27.3% - Defense World
5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Week - Benzinga
Corient Private Wealth LLC Acquires 1,892 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) - Defense World
(ACHC) Investment Analysis and Advice - Stock Traders Daily
Why Acadia Healthcare Company Inc (NASDAQ: ACHC) Is A Great Stock Pick For Momentum Investors - Stocks Register
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Acadia Healthcare Company, Inc. (ACHC) And Encourages Stockholders to Reach Out - Markets Insider
Acadia take-private scenario would make sense at $40-$50/sh, says Raymond James - Yahoo Finance
New Strong Sell Stocks for March 27th - TradingView
Raymond James maintains $40 target on Acadia Healthcare stock By Investing.com - Investing.com Canada
Raymond James Reaffirms Their Buy Rating on Acadia Healthcare (ACHC) - The Globe and Mail
Acadia Healthcare (NASDAQ:ACHC) Price Target Cut to $37.00 by Analysts at Mizuho - Defense World
Raymond James Financial Inc. Purchases New Stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) - Defense World
Online Cognitive Behavioral Therapy Market Set to Witness - openPR
Bronstein, Gewirtz & Grossman, LLC Is Investigating Acadia Healthcare Company, Inc. (ACHC) And Encourages Stockholders to Connect - Markets Insider
Acadia Healthcare Company Inc Stock (ACHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.16%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):